cesarean section. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: rupivacaine - Dexedodomidine. Intervention 2: Intervention group: rupivacaine - fentanyl.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Elective Cesarean section with Class I and II ASA
Exclusion criteria
Exclusion criteria: Preterm labor (less than 37 weeks) asthma cardiovascular disease preeclampsia history of seizures, becoming spinal anesthesia to complete anesthesia history of chronic pain such as low back pain and fibromyalgia, opioid use mood and Psychological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The patient's first time complaining of pain. Timepoint: The first time a patient feels pain after surgery. Method of measurement: Minutes.;The amount of analgesic drug. Timepoint: The onset of pain. Method of measurement: Mg / kg.;Rupivacaine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Dexedodomidine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Fentanyl. Timepoint: Before surgery. Method of measurement: Mg / kg. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Akhondzadeh
Ahvaz University of Medical Sciences
Outcome results
None listed